Breaking News Instant updates and real-time market news.

NVRO

Nevro

$60.50

16.45 (37.34%)

12:00
07/25/18
07/25
12:00
07/25/18
12:00

Nevro rises 36.8%

Nevro is up 36.8%, or $16.28 to $60.50.

  • 02

    Aug

  • 27

    Aug

NVRO Nevro
$60.50

16.45 (37.34%)

07/25/18
JPMS
07/25/18
NO CHANGE
Target $77
JPMS
Overweight
Nevro selloff yesterday a 'clear buying opportunity,' says JPMorgan
JPMorgan analyst Robbie Marcus views yesterday's selloff in shares of Nevro (NVRO) as a "clear buying opportunity." The headlines suggest Boston Scientific (BSX) was the clear winner in the summary judgment, but the "nuance in the actual ruling swings this in favor of Nevro," Marcus tells investors in a research note. The analyst's interpretation is that while Boston doesn't infringe Nevro's three remaining patents with its current trials and U.S. commercialized tonic stimulation devices, the ruling implies that any attempt to actually commercialize a high-frequency device in the U.S. remains an infringement of Nevro's remaining patents '102 and '472. While Nevro's systems claims patents were ruled invalid, the company's broader method claim patents were upheld, Marcus writes. He keeps an Overweight rating on Nevro with a $77 price target. The stock closed yesterday down 26%, or $15.78, to $44.22.
07/25/18
ADAM
07/25/18
NO CHANGE
Target $80
ADAM
Buy
Nevro weakness a buying opportunity, says Canaccord
Canaccord analyst Jason Mills said the weakness in Nevro (NVRO) following a summary judgment announced yesterday in its patent dispute with Boston Scientific (BSX) is a buying opportunity. The analyst said the move yesterday priced in a worst-case scenario, implying Nevro will lose all IP protection over its HF-10kHz technology, but he believes the current situation is more nuanced and the ultimate outcomes remain fluid. He believes the market overreacted and he recommends investors buy the weakness. Mills reiterated his Buy rating and $80 price target on Nevro shares.
07/25/18
LEER
07/25/18
NO CHANGE
Target $90
LEER
Outperform
Nevro selloff overdone, says Leerink
Leerink analyst Danielle Antalffy is defending Nevro (NVRO) shares after a 26% selloff in response to a summary judgment ruling in which either the company's patents were ruled invalid or Boston Scientific (BSX) was ruled to not infringe. The analyst believes that even in a worst-case scenario, namely one in which Nevro's patents are invalidated, allowing other manufacturers to pursue high frequency therapy, the company would still be able to grow sales by about 5% in 2019. Antalffy reiterates an Outperform rating and $90 price target on Nevro's shares as she continues to believe the company's fundamentals remain relatively strong, particularly given where the stock is currently trading.
07/25/18
WBLR
07/25/18
NO CHANGE
WBLR
Outperform
Nevro patent ruling not as bad as it seems, says William Blair
William Blair analyst Margaret Kaczor says the summary judgement issued yesterday is not as bad as it seems for Nevro (NVRO). While the initial headline appears negative, the ruling is similar to the preliminary judgment published earlier this month, Kaczor tells investors in a research note. Though some of the claims in the patents have been invalidated, the remaining claims, which include frequency ranges of 1.5 kHz to 100 kHz, were not invalidated, the analyst adds. She points out, though, that the judge found Boston Scientific (BSX) did not infringe on the claims as its commercially available devices could not be programmed to frequencies that would infringe and that devices that could be programmed to high frequency that are being used in clinical trials are included in safe harbor provisions. This leaves the door open in the event that Boston commercially launches a device within the frequency ranges referenced above, Kaczor writes. She believes, however, that even if Boston moves to launch a high frequency device in the United States, the company would likely have to file for FDA approval following the completion of its high-frequency trial. Despite some level of uncertainty this ruling may bring, Nevro's risk/reward is favorable, Kaczor contends. She keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

TRPX

Therapix Biosciences

$2.32

-0.02 (-0.85%)

09:20
07/23/19
07/23
09:20
07/23/19
09:20
Hot Stocks
Breaking Hot Stocks news story on Therapix Biosciences »

Therapix Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
07/23/19
07/23
09:18
07/23/19
09:18
Options
Overnight activity included 219 trades in SPX and 6 trades in VIX »

219 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$37.58

0.81 (2.20%)

09:17
07/23/19
07/23
09:17
07/23/19
09:17
Recommendations
Twitter analyst commentary at BMO Capital »

Twitter's delayed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

REAL

RealReal

$24.84

0.69 (2.86%)

09:17
07/23/19
07/23
09:17
07/23/19
09:17
Initiation
RealReal initiated  »

RealReal initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

TECH

Bio-Techne

$208.62

-0.61 (-0.29%)

09:17
07/23/19
07/23
09:17
07/23/19
09:17
Hot Stocks
Bio-Techne and Uman Diagnostic announce agreement »

Uman Diagnostics, now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 13

    Nov

ATEC

Alphatec

$4.60

0.1 (2.22%)

09:16
07/23/19
07/23
09:16
07/23/19
09:16
Hot Stocks
Alphatec announces commercial launch of InVictus spinal fixation platform »

Alphatec Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 12

    Sep

AMRH

AMERI Holdings

$0.34

-0.0098 (-2.80%)

, GOOG

Alphabet

$1,138.09

8.09 (0.72%)

09:15
07/23/19
07/23
09:15
07/23/19
09:15
Hot Stocks
AMERI Holdings advances Google partnership »

AMERI Holdings (AMRH)…

AMRH

AMERI Holdings

$0.34

-0.0098 (-2.80%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

  • 08

    Aug

  • 27

    Oct

09:15
07/23/19
07/23
09:15
07/23/19
09:15
General news
U.S. FHFA Home Price index rose 0.1% to 275.0 in May »

U.S. FHFA Home Price…

FCBP

First Choice Bank

$22.80

0.03 (0.13%)

09:14
07/23/19
07/23
09:14
07/23/19
09:14
Earnings
First Choice Bank announces Q1 EPS 58c, one est. 54c »

"Our larger scale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

09:12
07/23/19
07/23
09:12
07/23/19
09:12
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YVR

Liquid Media

$1.65

(0.00%)

09:11
07/23/19
07/23
09:11
07/23/19
09:11
Hot Stocks
Liquid Media says 'confident' Gaming Division is 'positioned for success' »

Liquid Media Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

09:10
07/23/19
07/23
09:10
07/23/19
09:10
Hot Stocks
Coca-Cola CEO says Powerade has not had good start to the year »

Says Dasani has faced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

WMT

Walmart

$112.80

-1.11 (-0.97%)

09:09
07/23/19
07/23
09:09
07/23/19
09:09
Recommendations
Walmart analyst commentary at Loop Capital »

Walmart price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Sep

  • 13

    Nov

CONE

CyrusOne

$58.69

0.48 (0.82%)

09:08
07/23/19
07/23
09:08
07/23/19
09:08
Hot Stocks
CyrusOne promotes Bill Williams to CIO »

CyrusOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

BIDU

Baidu

$111.74

-0.5 (-0.45%)

09:07
07/23/19
07/23
09:07
07/23/19
09:07
Downgrade
Baidu rating change at OTR Global »

Baidu downgraded to Mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

CECE

CECO Environmental

$8.88

0.01 (0.11%)

09:06
07/23/19
07/23
09:06
07/23/19
09:06
Hot Stocks
CECO Environmental announces important new order »

CECO Environmental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

  • 06

    Aug

SPY

SPDR S&P 500 ETF Trust

$297.82

0.65 (0.22%)

, SPX

S&P 500

$0.00

(0.00%)

09:06
07/23/19
07/23
09:06
07/23/19
09:06
General news
IMF lowers 2019 global growth forecast to 3.2%, 2020 growth view to 3.5% »

The IMF announced that…

SPY

SPDR S&P 500 ETF Trust

$297.82

0.65 (0.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$101.23

0.44 (0.44%)

09:06
07/23/19
07/23
09:06
07/23/19
09:06
Hot Stocks
Medtronic requests approval of non-adjunctive labeling from FDA »

Medtronic announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

AMID

American Midstream Partners

$5.24

(0.00%)

09:03
07/23/19
07/23
09:03
07/23/19
09:03
Hot Stocks
American Midstream Partners completes merger transactions with ArcLight Energy »

American Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:03
07/23/19
07/23
09:03
07/23/19
09:03
General news
FHFA House Price Index M/M change data reported »

May FHFA House Price…

LJPC

La Jolla

$8.54

-0.16 (-1.84%)

09:02
07/23/19
07/23
09:02
07/23/19
09:02
Hot Stocks
La Jolla receives orphan drug designation from FDA for LJPC-0118 »

La Jolla Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$91.23

-0.57 (-0.62%)

09:01
07/23/19
07/23
09:01
07/23/19
09:01
Hot Stocks
Arthur J. Gallagher acquires The Novick Group »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

, UTX

United Technologies

$132.94

0.57 (0.43%)

09:00
07/23/19
07/23
09:00
07/23/19
09:00
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS:…

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

UTX

United Technologies

$132.94

0.57 (0.43%)

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

CHMA

Chiasma

$6.19

-0.11 (-1.75%)

RLGY

Realogy

$5.17

-0.08 (-1.52%)

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

DGX

Quest Diagnostics

$98.07

-1.175 (-1.18%)

JBLU

JetBlue

$18.96

0.05 (0.26%)

CNC

Centene

$52.19

-0.46 (-0.87%)

HOG

Harley-Davidson

$34.25

-0.62 (-1.78%)

TTS

Tile Shop

$3.96

-0.12 (-2.94%)

ZION

Zions Bancorp

$45.16

-0.95 (-2.06%)

ACAD

Acadia

$25.97

0.28 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 23

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 20

    Aug

  • 09

    Sep

  • 19

    Sep

09:00
07/23/19
07/23
09:00
07/23/19
09:00
General news
U.S. equities are stronger »

U.S. equities are…

EFII

Electronics for Imaging

$36.97

(0.00%)

09:00
07/23/19
07/23
09:00
07/23/19
09:00
Hot Stocks
Electronics for Imaging announces completion of acquisition by Siris affiliate »

Electronics For Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.